ArticleFrontiers in medicine2025
Psychosomatic profile in patients with systemic sclerosis: results from an observational study.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cognitive impairment, depression, and anxiety in systemic sclerosis.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: The aim of the present study was to test whether the occurrence of psychosomatic syndromes in patients with systemic sclerosis (SSc) may influence psychopathological distress and well-being. Methods: A total of 276 outpatients with SSc were consecutively enrolled. Mental disorders were assessed using the Mini-International Neuropsychiatric Interview (MINI), while psychosomatic syndromes were assessed using the Semi-Structured Interview for Diagnostic Criteria for Psychosomatic Research-Revised (DCPR-R-SSI). Psychological distress and well-being were assessed using the Mental Pain Questionnaire (MPQ), the Symptom Questionnaire (SQ), the Psychological Well-Being (PWB) scales, the 5-item World Health Organization Well-Being Index (WHO-5), the Euthymia Scale (ES), and the Pictorial Representation of Illness and Self Measure (PRISM). Latent Class Analysis (LCA) was performed on the 14 items of the DCPR-R-SSI. The LCA solution identified two distinct latent patient groups with distinct clinical profiles: LC1, comprising 255 patients (92.4%), and LC2, comprising 21 patients (7.6%). Results: DCPR-R allostatic overload, demoralization, irritable mood, type a behavior, and alexithymia primarily discriminated between the two distinct latent groups of patients. The probabilities of observing these syndromes were higher among the patients belonging to the LC2 group. Depression was found to be associated with belonging to the LC2 group, as well as with higher scores on the MPQ and the SQ scales for depression, anxiety, anger-hostility, and somatization ( Conclusion: Psychosomatic syndromes may help define distinct clusters among patients with SSc, reflecting specific clinical profiles that should be considered during patient assessment and when proposing tailored interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.